Cytokinetics Inc CYTK
15 trading plans running, 30 Form 144 notices for $48.9M
10-Q, 10-K and Form 144What CYTK's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Mar 2, 2026 to May 16, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Robert I. Blum President and Chief Executive Officer |
Adopted 10b5-1 plan | Sep 11, 2026 | 10-Q Nov 4, 2026 |
| Robert A. Harrington member of our board of directors |
Adopted 10b5-1 plan | Aug 31, 2026 | 10-Q Nov 4, 2026 |
| Sung H. Lee Executive Vice President, Chief Financial Officer |
Adopted 10b5-1 plan | Aug 31, 2026 | 10-Q Nov 4, 2026 |
| Andrew Callos Executive Vice President, Chief Commercial Officer |
Adopted 10b5-1 plan | Aug 25, 2026 | 10-Q Nov 4, 2026 |
| Fady I. Malik Executive Vice President, Research and Development |
Adopted 10b5-1 plan | Aug 24, 2026 | 10-Q Nov 4, 2026 |
| John T. Henderson Chairman of our board of directors |
Adopted 10b5-1 plan | Aug 24, 2026 | 10-Q Nov 4, 2026 |
| B. Lynne Parshall member of our board of directors |
Adopted 10b5-1 plan | Aug 10, 2026 | 10-Q Nov 4, 2026 |
| Robert E. Landry | Adopted 10b5-1 plan | Jun 12, 2026 | 10-Q Aug 6, 2026 |
| Wendell Wierenga | Adopted 10b5-1 plan | Jun 10, 2026 | 10-Q Aug 6, 2026 |
| Edward M. Kaye M.D |
Adopted 10b5-1 plan | Mar 2, 2026 | 10-Q May 5, 2026 |
| Robert Blum President & Chief Executive Officer |
Ended other arrangement | Dec 31, 2025 | 10-Q May 10, 2024 |
| Robert I. Blum President & Chief Executive Officer |
Adopted 10b5-1 plan | Dec 24, 2025 | 10-K Feb 26, 2026 |
| Fady Malik Executive Vice President, Research & Development |
Adopted 10b5-1 plan | Dec 23, 2025 | 10-K Feb 26, 2026 |
| Sung Lee Executive Vice President & Chief Financial Officer |
Adopted 10b5-1 plan | Dec 23, 2025 | 10-K Feb 26, 2026 |
| Robert I. Blum President & Chief Executive Officer |
Ended 10b5-1 plan | Nov 14, 2025 | 10-K Feb 27, 2025 |
| Andrew Callos | Adopted 10b5-1 plan | Sep 5, 2025 | 10-Q Nov 5, 2025 |
| John T. Henderson | Adopted 10b5-1 plan | Sep 2, 2025 | 10-Q Nov 5, 2025 |
| B. Lynne Parshall | Adopted 10b5-1 plan | Aug 20, 2025 | 10-Q Nov 5, 2025 |
| Wendell Wierenga | Adopted 10b5-1 plan | May 14, 2025 | 10-Q Aug 7, 2025 |
| Robert A. Harrington | Adopted 10b5-1 plan | May 9, 2025 | 10-Q Aug 7, 2025 |
| Wendell Wierenga Director, Chair of the Science and Technology Committee |
Ended other arrangement | May 9, 2025 | 10-Q May 10, 2024 |
| Edward M. Kaye M.D |
Adopted 10b5-1 plan | Mar 6, 2025 | 10-Q May 6, 2025 |
| Andrew Callos Executive Vice President, Chief Commercial Officer |
Ended other arrangement | Mar 4, 2025 | 10-Q May 10, 2024 |
| Edward M. Kaye Director |
Ended other arrangement | Mar 4, 2025 | 10-Q May 10, 2024 |
| Fady Malik Executive Vice President, Research and Development |
Ended other arrangement | Dec 13, 2024 | 10-Q May 10, 2024 |
| Andrew Callos Executive Vice President, Chief Commercial Officer |
Adopted 10b5-1 plan | Dec 12, 2024 | 10-K Feb 27, 2025 |
| Santo J. Costa Director, Chair of the Compensation and Talent Committee |
Ended other arrangement | Dec 5, 2024 | 10-Q May 10, 2024 |
| Muna Bhanji Director |
Adopted 10b5-1 plan | Nov 18, 2024 | 10-K Feb 27, 2025 |
| Robert Harrington Director |
Adopted 10b5-1 plan | Nov 8, 2024 | 10-K Feb 27, 2025 |
| Robert Wong Vice President, Chief Accounting Officer |
Ended other arrangement | Sep 30, 2024 | 10-Q May 10, 2024 |
| B. Lynne Parshall Director, Chair of the Audit Committee |
Ended other arrangement | Sep 20, 2024 | 10-Q May 10, 2024 |
| Fady Malik Executive Vice President, Research & Development |
Adopted 10b5-1 plan | Sep 16, 2024 | 10-K Feb 27, 2025 |
| Fady Malik Executive Vice President, Research and Development |
Adopted 10b5-1 plan | Sep 16, 2024 | 10-Q Nov 7, 2024 |
| John T. Henderson Chairman of our Board of Directors |
Adopted 10b5-1 plan | Sep 11, 2024 | 10-K Feb 27, 2025 |
| John T. Henderson Chairman of our Board of Directors |
Adopted 10b5-1 plan | Sep 11, 2024 | 10-Q Nov 7, 2024 |
| Robert Harrington Director |
Ended other arrangement | Jul 31, 2024 | 10-Q May 10, 2024 |
| Muna Bhanji Director |
Ended other arrangement | Jul 24, 2024 | 10-Q May 10, 2024 |
| John T. Henderson Chairman of our Board of Directors |
Ended other arrangement | May 25, 2024 | 10-Q Nov 3, 2023 |
| Wendell Wierenga Member of our Board of Directors |
Ended other arrangement | May 21, 2024 | 10-Q Nov 3, 2023 |
| Fady I. Malik Vice President, Research and Development |
Ended other arrangement | May 8, 2024 | 10-Q Nov 3, 2023 |
| Ching W. Jaw Senior Vice President & Chief Financial Officer |
Ended 10b5-1 plan | Jun 30, 2023 | 10-Q Aug 3, 2023 |
| John T. Henderson Chairman of our Board of Directors |
Ended 10b5-1 plan | May 15, 2023 | 10-Q Aug 3, 2023 |
Show the other 34 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 5, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 9, 2026 | B LYNNE PARSHALL Director |
5,000 | $268K |
| Oct 20, 2026 | FADY MALIK Officer |
16,386 | $1.0M |
| Oct 13, 2026 | ROBERT BLUM Director, Officer |
22,500 | $1.4M |
| Sep 15, 2026 | Robert I. Blum President, CEO, Director |
97,926 | $7.1M |
| Sep 11, 2026 | ROBERT LANDRY Director |
2,000 | $147K |
| Sep 1, 2026 | B LYNNE PARSHALL Director |
5,000 | $355K |
| Jul 30, 2026 | ANDREW CALLOS Officer |
24,000 | $1.9M |
| Jul 7, 2026 | FADY MALIK Officer |
24,500 | $2.1M |
| Jul 1, 2026 | ROBERT BLUM Director, Officer |
52,500 | $4.5M |
| Jun 29, 2026 | Sung Lee Officer |
9,503 | $781K |
| Jun 26, 2026 | Sung Lee Officer |
6,695 | $541K |
| Jun 24, 2026 | Sung Lee Officer |
38,730 | $3.1M |
| Jun 1, 2026 | EDWARD KAYE Director |
2,933 | $225K |
| May 5, 2026 | WENDELL WIERENGA Director |
4,032 | $266K |
| May 5, 2026 | JOHN HENDERSON Director |
20,000 | $1.3M |
| May 5, 2026 | SUNG LEE Officer |
23,906 | $1.6M |
| Apr 15, 2026 | ANDREW CALLOS Officer |
79,639 | $5.3M |
| Apr 7, 2026 | FADY MALIK Officer |
22,000 | $1.4M |
| Apr 1, 2026 | ROBERT BLUM Director, Officer |
45,000 | $3.0M |
| Mar 31, 2026 | ANDREW CALLOS Officer |
3,639 | $229K |
| Mar 18, 2026 | ANDREW CALLOS Officer |
1,930 | $120K |
| Mar 16, 2026 | ANDREW CALLOS Officer |
1,709 | $103K |
| Mar 2, 2026 | B LYNNE PARSHALL Director |
10,000 | $622K |
| Jan 2, 2026 | ANDREW CALLOS Officer |
59,570 | $3.8M |
| Dec 29, 2025 | ANDREW CALLOS Officer |
1,809 | $114K |
| Dec 22, 2025 | WENDELL WIERENGA Director |
20,000 | $1.3M |
| Dec 5, 2025 | ANDREW CALLOS Officer |
53,528 | $3.6M |
| Dec 2, 2025 | JOHN T HENDERSON Director |
8,750 | $578K |
| Dec 1, 2025 | EDWARD KAYE Director |
28,064 | $1.9M |
| Nov 19, 2025 | B LYNNE PARSHALL Director |
5,000 | $331K |
Show the other 22 notices
From the Form 144 XML filed with the SEC, since Nov 19, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CYTK/export.csv") into a cell.